These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 9368350)
1. Stem cell gene therapy, position effects and chromatin insulators. Neff T; Shotkoski F; Stamatoyannopoulos G Stem Cells; 1997; 15 Suppl 1():265-71. PubMed ID: 9368350 [TBL] [Abstract][Full Text] [Related]
2. Prospects and implications of using chromatin insulators in gene therapy and transgenesis. Recillas-Targa F; Valadez-Graham V; Farrell CM Bioessays; 2004 Jul; 26(7):796-807. PubMed ID: 15221861 [TBL] [Abstract][Full Text] [Related]
3. Sea urchin insulator protects lentiviral vector from silencing by maintaining active chromatin structure. Hino S; Fan J; Taguwa S; Akasaka K; Matsuoka M Gene Ther; 2004 May; 11(10):819-28. PubMed ID: 14985785 [TBL] [Abstract][Full Text] [Related]
4. Gene transfer into nonhuman primate hematopoietic stem cells: implications for gene therapy. Hanazono Y; Terao K; Ozawa K Stem Cells; 2001; 19(1):12-23. PubMed ID: 11209087 [TBL] [Abstract][Full Text] [Related]
5. Insulation from viral transcriptional regulatory elements improves inducible transgene expression from adenovirus vectors in vitro and in vivo. Steinwaerder DS; Lieber A Gene Ther; 2000 Apr; 7(7):556-67. PubMed ID: 10819570 [TBL] [Abstract][Full Text] [Related]
6. Successful correction of the human Cooley's anemia beta-thalassemia major phenotype using a lentiviral vector flanked by the chicken hypersensitive site 4 chromatin insulator. Malik P; Arumugam PI; Yee JK; Puthenveetil G Ann N Y Acad Sci; 2005; 1054():238-49. PubMed ID: 16339671 [TBL] [Abstract][Full Text] [Related]
7. Genetic treatment of severe hemoglobinopathies: the combat against transgene variegation and transgene silencing. Rivella S; Sadelain M Semin Hematol; 1998 Apr; 35(2):112-25. PubMed ID: 9565154 [TBL] [Abstract][Full Text] [Related]
8. The insulation of genes from external enhancers and silencing chromatin. Burgess-Beusse B; Farrell C; Gaszner M; Litt M; Mutskov V; Recillas-Targa F; Simpson M; West A; Felsenfeld G Proc Natl Acad Sci U S A; 2002 Dec; 99 Suppl 4(Suppl 4):16433-7. PubMed ID: 12154228 [TBL] [Abstract][Full Text] [Related]
9. Progress toward the genetic treatment of the beta-thalassemias. Sadelain M; Lisowski L; Samakoglu S; Rivella S; May C; Riviere I Ann N Y Acad Sci; 2005; 1054():78-91. PubMed ID: 16339654 [TBL] [Abstract][Full Text] [Related]
10. Designing nonviral vectors for efficient gene transfer and long-term gene expression. Jackson DA; Juranek S; Lipps HJ Mol Ther; 2006 Nov; 14(5):613-26. PubMed ID: 16784894 [TBL] [Abstract][Full Text] [Related]
11. The cHS4 chromatin insulator reduces gammaretroviral vector silencing by epigenetic modifications of integrated provirus. Li CL; Emery DW Gene Ther; 2008 Jan; 15(1):49-53. PubMed ID: 17989708 [TBL] [Abstract][Full Text] [Related]
12. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human beta-globin gene in hematopoietic cells from homozygous beta-thalassemic mice. Tan M; Qing K; Zhou S; Yoder MC; Srivastava A Mol Ther; 2001 Jun; 3(6):940-6. PubMed ID: 11407908 [TBL] [Abstract][Full Text] [Related]
13. High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors. Ma Y; Ramezani A; Lewis R; Hawley RG; Thomson JA Stem Cells; 2003; 21(1):111-7. PubMed ID: 12529558 [TBL] [Abstract][Full Text] [Related]
15. Expression from second-generation feline immunodeficiency virus vectors is impaired in human hematopoietic cells. Price MA; Case SS; Carbonaro DA; Yu XJ; Petersen D; Sabo KM; Curran MA; Engel BC; Margarian H; Abkowitz JL; Nolan GP; Kohn DB; Crooks GM Mol Ther; 2002 Nov; 6(5):645-52. PubMed ID: 12409263 [TBL] [Abstract][Full Text] [Related]
16. A phase I/II clinical trial of beta-globin gene therapy for beta-thalassemia. Bank A; Dorazio R; Leboulch P Ann N Y Acad Sci; 2005; 1054():308-16. PubMed ID: 16339679 [TBL] [Abstract][Full Text] [Related]
17. [Development of gene therapy for hematopoietic stem cell using viral vectors]. Dong WJ; Zu ZX; Liu DP; Liang CC Yi Chuan Xue Bao; 2003 Apr; 30(4):382-8. PubMed ID: 12812066 [TBL] [Abstract][Full Text] [Related]
18. Boundary sequences stabilize transgene expression from subtle position effects in retroviral vectors. Moreno R; Martinez I; Petriz J; González JR; Gratacós E; Aran JM Blood Cells Mol Dis; 2009; 43(2):214-20. PubMed ID: 19632138 [TBL] [Abstract][Full Text] [Related]
19. New vectors for gene therapy. Grez M; von Melchner H Stem Cells; 1998; 16 Suppl 1():235-43. PubMed ID: 11012167 [TBL] [Abstract][Full Text] [Related]
20. Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice. Kikuchi J; Mimuro J; Ogata K; Tabata T; Ueda Y; Ishiwata A; Kimura K; Takano K; Madoiwa S; Mizukami H; Hanazono Y; Kume A; Hasegawa M; Ozawa K; Sakata Y J Gene Med; 2004 Oct; 6(10):1049-60. PubMed ID: 15386735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]